Mitochondrial-derived peptide (MDP)
A short peptide produced from mitochondrial DNA—MOTS-c is the most discussed example.
A short peptide produced from mitochondrial DNA—MOTS-c is the most discussed example.
A short peptide produced from mitochondrial DNA—MOTS-c is the most discussed example. Mitochondria have their own genome. Small open reading frames in mtDNA can encode peptides that signal back to the nucleus and other tissues—sometimes called mitokines. MOTS-c is the flagship MDP in metabolic and aging research. Distinct from nuclear-encoded peptides like BPC-157 or GLP-1 drugs.
Prescription peptide drugs require medical supervision, pharmacy dispensing, and diagnosis—they are not interchangeable with topical cosmetic peptides or bulk supplement powders.
A short peptide produced from mitochondrial DNA—MOTS-c is the most discussed example. Mitochondria have their own genome. Small open reading frames in mtDNA can encode peptides that signal back to the nucleus and other tissues—sometimes called mitokines. MOTS-c is the flagship MDP in metabolic and aging research. Distinct from nuclear-encoded peptides like BPC-157 or GLP-1 drugs.
No. Prescription peptide drugs are medicines, not cosmetic or bulk-powder ingredients. They require a clinician and regulated pharmacy supply chain.